| 1 | [Inebilizumab] | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 300 300 💬
|
| 2 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [8] 11 11, 13, 46, 49, 51, 53, 95, 300 💬
|
| 3 | Inebilizumab + Rapid Steroid Tapering group | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 4 | Inebilizumab + Standard Steroid Tapering group | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 5 | Rapid-tapering glucocorticoids + Inebilizumab | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|
| 6 | Slow-tapering glucocorticoids + Inebilizumab | [1] Inebilizumab Inebilizumab (inebilizumab-cdon) | [1] Inebilizumab
Inebilizumab
(Inebilizumab, Inebilizumab-cdon) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [1] 13 13 💬
|